Our data demonstrated that embelin is able to change the mitochondrial membrane potential to promote a change in the levels of Bax and Bcl-2 as well as the release of cytochrome C, which results in the apoptosis of MCF-7 breast cancer cells. This evidence concerns the gene BAX and breast cancer.